The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126157881 12615788 1 I 20160719 20160721 20160802 20160802 EXP PHHO2016US010642 SANDOZ 95.66 YR M Y 76.20000 KG 20160802 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126157881 12615788 1 PS FUROSEMIDE. FUROSEMIDE 1 Oral 4 DF, BID 18569 4 DF BID
126157881 12615788 2 SS BLINDED NO TREATMENT RECEIVED INVESTIGATIONAL PRODUCT 1 Intravenous (not otherwise specified) CODE NOT BROKEN 0 INJECTION
126157881 12615788 3 SS BLINDED PLACEBO INVESTIGATIONAL PRODUCT 1 Intravenous (not otherwise specified) CODE NOT BROKEN 0 INJECTION
126157881 12615788 4 SS BLINDED RLX030 SERELAXIN 1 Intravenous (not otherwise specified) CODE NOT BROKEN 0 INJECTION
126157881 12615788 5 C ASPIRIN. ASPIRIN 1 Oral 81 MG, QD 0 81 MG TABLET QD
126157881 12615788 6 C DOCUSATE SODIUM. DOCUSATE SODIUM 1 Oral 100 MG, BID (AS NEEDED) 9000 MG 0 100 MG CAPSULE BID
126157881 12615788 7 C ESOMEPRAZOLE ESOMEPRAZOLE 1 Oral 20 MG, (EVERY MORNING) 0 20 MG
126157881 12615788 8 C HYDROCORTISONE. HYDROCORTISONE 1 Oral 10 MG,(EVERY MORNING) 0 10 MG
126157881 12615788 9 C METOPROLOL TARTRATE. METOPROLOL TARTRATE 1 Oral 37.5 MG, BID 3375 MG 0 37.5 MG BID
126157881 12615788 10 C METOPROLOL TARTRATE. METOPROLOL TARTRATE 1 3375 MG 0
126157881 12615788 11 C SIMVASTATIN. SIMVASTATIN 1 Oral 10 MG (NIGHT) 0 10 MG
126157881 12615788 12 C TAMSULOSIN TAMSULOSIN 1 Oral 0.4 MG, QD 18 MG 0 .4 MG CAPSULE QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126157881 12615788 1 Cardiac failure congestive
126157881 12615788 2 Cardiac failure acute
126157881 12615788 3 Cardiac failure acute
126157881 12615788 4 Cardiac failure acute
126157881 12615788 5 Prophylaxis
126157881 12615788 6 Constipation prophylaxis
126157881 12615788 7 Gastrooesophageal reflux disease
126157881 12615788 8 Adrenal insufficiency
126157881 12615788 9 Hypertension
126157881 12615788 10 Atrial fibrillation
126157881 12615788 11 Hyperlipidaemia
126157881 12615788 12 Benign prostatic hyperplasia

Outcome of event

Event ID CASEID OUTC COD
126157881 12615788 HO
126157881 12615788 OT
126157881 12615788 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
126157881 12615788 Cardiac failure
126157881 12615788 Pleural effusion
126157881 12615788 Renal impairment

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126157881 12615788 1 20160612 20160719 0
126157881 12615788 2 20160707 20160709 0
126157881 12615788 3 20160707 20160709 0
126157881 12615788 4 20160707 20160709 0
126157881 12615788 5 2013 20160719 0
126157881 12615788 6 20160605 20160719 0
126157881 12615788 7 1991 20160719 0
126157881 12615788 8 20160605 20160719 0
126157881 12615788 9 20160605 20160719 0
126157881 12615788 11 2001 20160719 0
126157881 12615788 12 20160605 20160719 0